JnJ gets USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma who are transplant-eligible Ruchika Sharma2 Aug 2024 11:30 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved DARZALEX FASPRO (daratumumab and...
Blenrep combinations in multiple myeloma application accepted for review by EMA: GSK Ruchika Sharma20 July 2024 3:30 PM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for...
Prophylactic Role of Perioperative Corticosteroids for Postoperative Neurocognitive Dysfunction- metaanalysis Dr Monish Raut12 May 2024 7:45 PM ISTRecent research paper titled "Effect of prophylactic corticosteroids on postoperative neurocognitive dysfunction in the adult population: An updated...
Is intratympanic oxytocin effective for treating cisplatin induced ototoxicity? Study sheds light Medha Baranwal29 April 2024 11:45 PM ISTTurkey: In a groundbreaking experimental study, researchers have compared the effectiveness of intratympanic oxytocin and dexamethasone in combating...
Short dexamethasone therapy does not increase infection risk in diabetes patients undergoing arthroplasty Jacinthlyn Sylvia19 Jan 2024 5:00 PM ISTThe Journal of Arthroplasty recently published a study presenting compelling evidence opposing the practice of withholding dexamethasone in patients...
Delhi fake drugs row: AAP govt issues direction to replace failed drugs Roshni Dhar26 Dec 2023 5:44 PM ISTDelhi Cabinet Minister Saurabh Bharadwaj on Sunday directed the health secretary to make alternative arrangements for the five drugs that failed...
Make alternative arrangements for 5 failed drugs to be withdrawn: Delhi Cabinet Minister to health secretary Ruchika Sharma26 Dec 2023 5:30 PM ISTIn the communication to the health secretary, Bharadwaj said he had learnt that the vigilance department issued directions to immediately remove the...
Health Bulletin 26/December/2023 Roshni Dhar26 Dec 2023 4:25 PM ISTHere are the top health stories for the day:NExT now mandatory after BAMS, BSMS, BUMS courses regulations releasedAfter MBBS and BDS, the National...
Sarclisa plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone: Sanofi Ruchika Sharma11 Dec 2023 2:30 PM ISTParis: Sanofi has announced that the Phase 3 trial investigating Sarclisa (isatuximab) in combination with carfilzomib, lenalidomide and...
Sanofi multiple myeloma drug Sarclisa phase 3 trial meets primary endpoint of progression-free survival Ruchika Sharma10 Dec 2023 11:30 AM ISTParis: Sanofi has announced that the Phase 3 IMROZ trial evaluating the investigational use of Sarclisa (isatuximab) in combination with...
Medical Bulletin 02/December/2023 Preksha garg2 Dec 2023 3:00 PM ISTHere are the top medical news of the day:High-doses of Covid medicines not effective in India than EuropeAccording to a new study published in The...
High-doses of Covid medicines not effective in India than Europe Preksha garg2 Dec 2023 9:00 AM ISTAccording to a new study published in The Lancet Regional Health - Southeast Asia journal higher doses of the COVID-19 drug, dexamethasone, may have...
